Examining Variations in Elective Surgery Prices Across the U.S.

Lantern partnered with Merative to use MarketScan data to analyze price variation for six common elective surgeries over 2021-2023 across 10 diverse US metropolitan areas, addressing persistent regional cost and pricing-transparency concerns. The webpage confirms this scope but does not state the actual dollar figures or variation findings; those are only in a downloadable PDF whitepaper that was not reachable via fetch.

Merative is the former IBM Watson Health, now an independent company behind the MarketScan claims database and the Zelta clinical-trial platform.

This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.